Superworth

Heron Therapeutics EPS HRTX

Diluted earnings per share by quarter and over the last twelve months, from 2010.

Last 12 months, to Jun 30, 2026
−$0.19
Latest quarter, Q2 FY26
−$0.03
Fiscal year 2025
−$0.13

Heron Therapeutics' earnings per share was −$0.19 over the twelve months to Jun 30, 2026.

In its latest quarter, Q2 FY26, it was −$0.03.

Earnings per share over time

Open the interactive chart, with overlays and comparisons

Fiscal year by fiscal year

Fiscal yearEPSChange
FY2025−$0.13n/a
FY2024−$0.09n/a
FY2023−$0.86n/a
FY2022−$1.73n/a
FY2021−$2.25n/a
FY2020−$2.50n/a
FY2019−$2.50n/a
FY2018−$2.47n/a
FY2017−$3.66n/a
FY2016−$4.55n/a
FY2015−$2.94n/a
FY2014−$2.89n/a
FY2013−$3.45n/a
FY2012−$2.27n/a
FY2011−$2.60n/a

Each fiscal year is the twelve months to its fourth quarter.

Quarter by quarter

QuarterEndedEPSOn a year earlierLast 12 months
Q2 FY26−$0.03n/a−$0.19
Q1 FY26−$0.04−500%−$0.18
Q4 FY25−$0.02−200%−$0.13
Q3 FY25−$0.10n/a−$0.09
Q2 FY25−$0.02n/a−$0.02
Q1 FY25$0.01n/a−$0.06
Q4 FY24$0.02n/a−$0.09
Q3 FY24−$0.03n/a−$0.18
Q2 FY24−$0.06n/a−$0.32
Q1 FY24−$0.02n/a−$0.61
Q4 FY23−$0.07n/a−$0.86
Q3 FY23−$0.17n/a−$0.96

Against its peers

Companies in Drug Manufacturers - General nearest Heron Therapeutics' size, closest first, today.

CompanyEPS, 12 monthsGrowth
HRTXHeron Therapeutics−$0.19
SPROSpero Therapeutics$0.11
ATNMActinium Pharmaceuticals$0.36
LFVNLifevantage$0.40−46% a year
NATRNatures Sunshine Products$1.01+36% a year
ARVNArvinas$0.16
PBYIPuma Biotechnology$0.52−47% a year
IRWDIronwood Pharmaceuticals$0.77
Peer median$0.40

What the EPS figure tells you

Net income divided by diluted shares. The denominator of PE.

One-off charges and gains swing it. The TTM view smooths a single odd quarter.

More on Heron Therapeutics

Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.